United Kingdom Archives

News and Trends 20 Mar 2015

Optibrium introduces the lastest version of StarDrop

Cambridge-based Optibrium has launched of version 6.1 of its StarDrop platform to guide researchers in the design of high quality compounds in drug discovery, agrochemicals and other chemistry fields. The latest release introduces the Matsy technology, based on matched molecular series analysis, which proposes strategies for chemical substitutions to optimise compound activity. Also included is […]

March 20, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 12 Mar 2015

Alderley Park Life Science Campus, on the go

Manchester Science Partnerships (MSP) and Bruntwood have revealed plans for the first phase of development at their flagship 162-hectare life science campus at Alderley Park, Cheshire. The plans centered on the Mereside science campus and were revealed at MIPIM – the annual international property conference held in Cannes, France. The session, titled ‘Translating Science into […]

March 12, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Mar 2015

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

Today, it has been accepted! The first drug approved through the Early Access to Medicine Scheme (EAMS), named pembrolizumab, is an immunotherapy treatment for advanced melanoma. The treatment has been developed by Merck, known as MSD outside the United States and Canada, with early development work carried out using MRC Technology’s antibody humanization expertise. EAMS is […]

March 11, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Mar 2015

Vitic database, the new must-have tool

The latest version of the Vitic Intermediates database, chemical database and information management system, has been released by Lhasa Limited, a leading global supplier of knowledge based software and associated databases. Initiated in 2006, Vitic Intermediates is a cross industry data sharing consortium created and co-ordinated by Lhasa Limited, through the Vitic Nexus platform, supported by […]

March 11, 2015 - 3 minutesmins - By Lourdes Riquelme

Philosophical Transactions 350 anniversary

News and Trends 10 Mar 2015

350th anniversary of Philosophical Transactions, the first scientific journal

The world’s oldest continuously published journal, Philosophical Transactions of the Royal Society of London (RSL), celebrates its 350th anniversary on 6 March 2015. Academic journals are the cornerstone of science research. They serve as showcases, forums where researchers present their discoveries to the scientific community so they can be scrutinized, criticized and confirmed or rejected. […]

March 10, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 6 Mar 2015

Petunica circadia, where Art and Biotechnology meet

A changing-color flower that goes from blue to red and viceversa? It may sound like science fiction, but it’s purely biotechnology. A simple petunia to make a statement: gene engineering is not something to be afraid of. Biotechnology has so many applications that go from nourishing the increasing world population to growing beautiful flowers to […]

March 6, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 5 Mar 2015

Novartis announces completion of transactions with GSK

Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint venture, and sale of non-influenza Vaccines business Sharpens company focus on growing segments of innovative pharmaceuticals, eye care and generics Addition of GSK oncology products and two pipeline compounds is expected to expand Novartis position in targeted therapies and small […]

March 5, 2015 - 5 minutesmins - By Cédric Brock

News and Trends 5 Mar 2015

Synpromics and UniQure, new Collaboration in Gene Therapy.

Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene therapies to liver. Synpromics, a leading synthetic biology company, will use its unique approach to develop synthetic promoters with upregulated, liver cell specific, activity whilst also decreasing the promoter molecular […]

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

Orca Pharmaceuticals AstraZeneca autoimmune2

News and Trends 27 Feb 2015

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (RORγ). Inhibitors of this receptor are believed to have potential against a wide range of autoimmune diseases for which there is currently no safe, orally available and effective treatment. RORγ plays a key role in […]

February 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Feb 2015

Ipsen buys an option to Acquire Canbex

Canbex, a spin-off of University College London (UCL) that raised a Series A financing of €2.8M in 2013 from MS Ventures, may become part of Ipsen. The French giant payed €6M upfront for the option to purchase 100% of Canbex shares upon completion of the Phase IIa study of Canbex’s lead candidate for the treatment […]

February 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 24 Feb 2015

Cobra Biologics and Manchester University Awarded €296.4K

The University of Manchester and Cobra Biologics, biologics and pharmaceuticals manufacturer, have been awarded €296.4K by Innovate UK and the Biotechnology and Biological Sciences Research Council (BBSRC). The project is one of the only 23 which will share almost €27.3M given away by the competition that intends to bring innovative biotechnology projects to market. The joint […]

February 24, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Feb 2015

Great news for Great Britain’s synthetic biology

British government will inject the impressive amount of £40M to reinforce UK’s leading position in synthetic biology. UK Business Secretary Vince Cable has announced a £40M investment in UK synthetic biology at the Manchester Institute for Biotechnology. The majority of this investment, £32M, will be used to establish three new Synthetic Biology Research Centres at […]

February 16, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Optibrium introduces the lastest version of StarDrop

Alderley Park Life Science Campus, on the go

First Treatment Approved under Early Access to Medicine Scheme (EAMS)

Vitic database, the new must-have tool

350th anniversary of Philosophical Transactions, the first scientific journal

Petunica circadia, where Art and Biotechnology meet

Novartis announces completion of transactions with GSK

Synpromics and UniQure, new Collaboration in Gene Therapy.

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Ipsen buys an option to Acquire Canbex

Cobra Biologics and Manchester University Awarded €296.4K

Great news for Great Britain’s synthetic biology

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!